tirzepatide News
Latest articles and news about tirzepatide on AXL Media.
Latest Articles
- Pharmaceutical Peak Body Slams "Broken" PBS System as Mounjaro Subsidy Stalls
Published: Apr 28, 2026
Section: Medical News
Medicines Australia has labeled the nation's drug subsidy process "broken" after negotiations to list the diabetes medication Mounjaro on the Pharmaceutical Benefits Scheme (PBS) c...
- New Clinical Guidelines Advise Nurse Practitioners on Expanding GLP-1 Receptor Agonist Indications and Risks
Published: Apr 28, 2026
Section: Medical News
A comprehensive review published in The Nurse Practitioner details the evolving role of GLP-1 receptor agonists beyond diabetes management into cardiovascular and renal protection....
- Interventional Cardiology Journal Releases Seven Key Studies Addressing Cardiometabolic and High-Acuity Cardiac Care
Published: Apr 25, 2026
Section: Research
The Journal of the Society for Cardiovascular Angiography & Interventions has simultaneously published seven original research papers during the SCAI 2026 Scientific Sessions in Mo...
- Experimental Endoscopic Gut Reset Procedure Shows Potential to Prevent Weight Regain After GLP-1 Cessation
Published: Apr 24, 2026
Section: Medical News
A new study presented at Digestive Disease Week 2026 indicates that duodenal mucosal resurfacing (DMR) may prevent the weight rebound commonly seen after stopping GLP-1 medications...
- Endoscopic "gut reset" procedure prevents weight rebound after stopping Ozempic and Wegovy
Published: Apr 23, 2026
Section: Research
A new minimally invasive technique called duodenal mucosal resurfacing (DMR) could solve the "weight regain" paradox for patients discontinuing GLP-1 medications. Clinical trial re...
- Endoscopic Duodenal Resurfacing Offers Breakthrough for Sustaining Weight Loss After Discontinuing GLP-1 Medications
Published: Apr 23, 2026
Section: Medical News
A randomized, sham-controlled trial presented at Digestive Disease Week 2026 suggests that duodenal mucosal resurfacing (DMR) significantly mitigates weight regain following the ce...
- AI Analysis of 400,000 Reddit Posts Uncovers Underreported GLP-1 Side Effects
Published: Apr 11, 2026
Section: Health
Researchers at the University of Pennsylvania have utilized advanced artificial intelligence to identify patient-reported symptoms associated with popular GLP-1 weight-loss and dia...
- AI Analysis of 400,000 Reddit Posts Identifies Unreported Side Effects Linked to Popular GLP-1 Weight-Loss Drugs
Published: Apr 10, 2026
Section: Medical News
University of Pennsylvania researchers utilized large language models to scan over half a decade of social media discussions regarding semaglutide and tirzepatide. The study uncove...
- New Genetic Study Identifies Why Some GLP-1 Users Lose More Weight and Face Higher Side Effect Risks
Published: Apr 10, 2026
Section: Health
A large-scale genome-wide association study (GWAS) involving nearly 28,000 participants has identified specific genetic variants in the GLP1R and GIPR genes that influence a patien...
- Clinical Study Warns of Critically Low Protein Intake and Nutritional Risks for GLP-1 Drug Users
Published: Apr 10, 2026
Section: Medical News
A real-world analysis of adults using GLP-1 receptor agonists, such as semaglutide and tirzepatide, has identified a significant risk of nutritional deficiency due to drastically r...
- New Genetic Study Identifies Why GLP-1 Weight Loss Efficacy and Side Effects Vary Between Patients
Published: Apr 8, 2026
Section: Health Technology
The 23andMe Research Institute has published a large-scale genome-wide association study in Nature identifying genetic markers that predict how individuals respond to GLP-1 medicat...
- Major UK Study Reveals 71% Higher Mortality and Cardiovascular Risk for Sleep Apnea Patients
Published: Apr 3, 2026
Section: Medical News
New research involving 2.9 million electronic health records indicates that individuals with obstructive sleep apnea (OSA) face a nearly double risk of cardiovascular events or dea...